MC4R and obesity due to melanocortin 4 receptor deficiency: On the other hand, findings from the UK Biobank (UKBB) general population and another analysis of approximately 17,000 individuals of European origin from nine independent cohorts revealed that carriers of GoF variants in MC4R exhibit lower BMI and a reduced risk of metabolic diseases, thereby contributing to a lower prevalence of obesity [21, 22].